Natasha C. Bergmann

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

Lærke S. Gasbjerg, Mads M. Helsted, Bolette Hartmann et al. · Diabetes · 2019 · 180 citations

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

Natasha C. Bergmann, Asger Lund, Lærke S. Gasbjerg et al. · Diabetologia · 2019 · 131 citations · Full text

Obesity, Nutrition, Metabolic Syndrome +13

Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes

Natasha C. Bergmann, Asger Lund, Lærke S. Gasbjerg et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 61 citations · Full text

GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals

Lærke S. Gasbjerg, Mads M. Helsted, Bolette Hartmann et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 61 citations · Full text

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

Natasha C. Bergmann, Lærke S. Gasbjerg, SEBASTIAN M. NGUYEN HEIMBÜRGER et al. · Diabetes Care · 2020 · 59 citations · Full text